HAROLD WEISSMAN, M.D.
Ophthalmology Physician · SUFFERN, NY
Individual Active NPI 1194886614
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 473 | 7,499 | $995,496 | $594,698 | $463,990 |
| 2023 | 506 | 5,492 | $916,665 | $517,194 | $394,620 |
| 2022 | 502 | 3,623 | $871,180 | $494,185 | $375,670 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,780 | $34 | $27 |
| 92134 | Imaging of retina | 912 | $49 | $37 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 874 | $18 | $14 |
| 92014 | Established patient complete exam of visual system | 528 | $151 | $112 |
| 92012 | Established patient problem focused exam of visual system | 391 | $108 | $81 |
| 67028 | Injection of drug into eye | 225 | $136 | $108 |
| J0178 | Injection, aflibercept, 1 mg | 182 | $828 | $660 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 116 | $29 | $22 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 73 | $202 | $144 |
| 92133 | Imaging of optic nerve | 49 | $44 | $35 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 30 | $201 | $162 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 28 | $57 | $46 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 124575 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1003116187
- NPI 1619956240
- NPI 1689653362
- NPI 1013269729
- NPI 1144324179
- NPI 1245487677
- NPI 1487633079
- NPI 1285418079
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.